Addressing Development and Use of Chemical and Biological Weapons by Russia

Addressing Development and Use of Chemical and Biological Weapons by Russia

ID: 359215Type: Posted

Overview

Buyer

Bureau of International Security-Nonproliferation (DOS-ISN)

Award Range

$250K - $10M

Eligible Applicants

Others

Funding Category

Other

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/359215

Additional Information

https://mygrants.servicenowservices.com/mygrants?id=mygrants_form&table=x_g_usd4_d_grant_funding_opportunity&sys_id=f849f20a1b356a50baa70fe4604bcb93&view=Default

Timeline

Description

The Bureau of International Security-Nonproliferation is offering a federal grant opportunity titled "Addressing Development and Use of Chemical and Biological Weapons by Russia." This initiative aims to engage the biological, biotechnology, chemical, and pharmaceutical industries in implementing best practices for compliance and due diligence to safeguard supply chains against Russian acquisition of materials for chemical and biological weapons (CBW) development. The program also includes training for first responders and laboratory staff in CBW detection methods, emphasizing the importance of cybersecurity in protecting detection processes. The total estimated funding for this program is $15 million, with individual awards ranging from $250,000 to $10 million, and applications are due by July 30, 2025. Interested applicants can reach out via email at ctrspecialprojectsproposals@state.gov for further information.

Point(s) of Contact

No information provided.

Files

Title

Size

Type

Posted

737 B

Document

[Content_Types].xml

2 KB

Document

91 KB

Binary

708 B

Document

656 B

Document

2 KB

Document

91 KB

Document

document.xml.rels

2 KB

Document

3 KB

Document

3 KB

Document

3 KB

Document

113 KB

Binary

43 KB

Binary

1 KB

Document

296 B

Document

270 B

Document

296 B

Document

219 B

Document

296 B

Document

17 KB

Document

296 B

Document

1 KB

Document

341 B

Document

335 B

Document

1 KB

Document

30 KB

Binary

17 KB

Document

6 KB

Document

35 KB

Document

7 KB

Document

webSettings.xml

4 KB

Document

Similar Opportunities

CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)

National Institutes of Health

The National Institutes of Health (NIH) is inviting applications for the CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) program, focusing on basic research related to chemical warfare agents and toxic industrial chemicals that impact the nervous system. The objective is to elucidate mechanisms of toxicity, identify biological markers, and develop potential therapeutic countermeasures for civilian populations exposed to these chemicals. This funding opportunity is critical for enhancing public safety against chemical threats, with a total of $2 million available for up to four awards, each with a maximum annual budget of $300,000 over three years. Interested applicants must submit their proposals by September 17, 2024, and can direct inquiries to grantsinfo@nih.gov for further information.

Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)

National Institutes of Health

The National Institutes of Health (NIH) is offering a grant opportunity titled "Promoting a Basic Understanding of Chemical Threats to Skin," aimed at small businesses interested in researching the pathological mechanisms of skin injuries caused by toxic chemicals. The initiative seeks to elucidate the commonalities in the mechanisms of skin injuries from various vesicants, such as sulfur mustard and Lewisite, with the goal of identifying shared therapeutic targets and developing broad-spectrum medical countermeasures for mass casualty events. The estimated total program funding is $2,500,000, with approximately five awards expected, and interested applicants are encouraged to collaborate and prepare their proposals ahead of the anticipated application period, which is expected to open in early 2026. For further inquiries, potential applicants can contact Dr. Peter J. Koch at Peter.Koch@NIH.gov or by phone at 240-987-8325.

CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)

National Institutes of Health

The National Institutes of Health (NIH) has announced a funding opportunity titled "NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System." This initiative invites applications for basic research projects focused on understanding the mechanisms of toxicity of chemical warfare agents and toxic industrial chemicals that impact the nervous system, with the aim of developing potential therapeutic countermeasures for civilian exposure. The program is particularly significant in enhancing public health responses to chemical threats, emphasizing innovative and transdisciplinary research approaches. Up to four grants totaling $2 million are anticipated for fiscal year 2026, with applications due by 5 PM local time on October 17, 2026. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.

Biological Threat Reduction with Global Partners Broad Agency Announcement (BAA)

Defense Threat Reduction Agency

The Defense Threat Reduction Agency (DTRA) has announced a Broad Agency Announcement (BAA) titled "Biological Threat Reduction with Global Partners," aimed at enhancing global health security against biological threats. This initiative invites submissions of Abstracts, White Papers, and Full Proposals from accredited universities, industry, and non-profit organizations to strengthen the capabilities of partner nations in preventing, detecting, and responding to biological threats, including diseases. The BAA emphasizes collaborative scientific studies to improve disease diagnostics, evaluate training programs, and establish biosecurity protocols, ultimately contributing to global biological threat reduction efforts. Interested applicants can find more information and submit proposals through the Grant Opportunities website, with the submission period running from April 29, 2024, to April 28, 2029. For inquiries, contact the CTR BAA Team at dtra.belvoir.ct.mbx.ctr-baa@mail.mil.

CCRP Initiative: Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms (R01 Clinical Trial Not Allowed)

National Institutes of Health

The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) titled "CCRP Initiative: Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms," aimed at supporting research into the mechanisms of chemical toxicity affecting the lungs and eyes. This initiative seeks to fund projects that explore the health impacts of chemical threat agents, with a focus on identifying molecular and genetic targets for therapeutic countermeasures, utilizing various research methodologies such as animal models and computational modeling. A total of approximately $3 million is available to support up to five grants, with each project eligible for a maximum budget of $300,000 per year over a three-year period. Interested applicants should note that the application period opens on August 24, 2024, with a final submission deadline of September 24, 2026, and can direct inquiries to grantsinfo@nih.gov for further information.

Enhancing global laboratory systems to safely manage biological risks, deploy diagnostics and sequence pathogens to strengthen health protection worldwide

Centers for Disease Control-GHC

The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement aimed at enhancing global laboratory systems to manage biological risks and improve health protection worldwide. The initiative focuses on strengthening public health laboratory systems, workforce development, bio risk management, emergency preparedness, laboratory quality management, and enhancing diagnostic capacities, particularly in low-resource settings. This funding opportunity, with an estimated total program funding of $25 million and expected to award three grants, is open to unrestricted applicants, with applications due by January 2, 2026. For further inquiries, interested parties can contact Broderick Yoerg at 404.234.0666 or via email at DGHPNOFOs@cdc.gov.

Notice of Intent to Publish a Funding Opportunity Announcement for CCRP Initiative: Countermeasures Against Chemical Threats (CounterACT) Therapeutics Discovery and Early-Stage Development (UG3/UH3 Clinical Trial Not Allowed)

National Institutes of Health

The National Institutes of Health (NIH) plans to publish a Notice of Funding Opportunity (NOFO) for the Countermeasures Against Chemical Threats (CounterACT) initiative, focusing on the early-stage development of therapeutics to address health impacts from toxic chemical exposure. This funding opportunity aims to foster collaborations and innovative projects that can effectively mitigate adverse health effects, with an emphasis on the UG3/UH3 activity code for phased development. The NOFO is anticipated to be released in early 2025, with applications due by October 2025, and awards expected to be made by June 2026, marking a significant investment in public health safety. Interested applicants should prepare to align their proposals with the outlined objectives and timelines.

US Army Combat Capabilities Development Command (DEVCOM) Indo-Pacific Fundamental Research Collaboration Opportunities

USAF 347 Contracting Squadron

The USAF 347 Contracting Squadron is offering a federal grant opportunity titled "US Army Combat Capabilities Development Command (DEVCOM) Indo-Pacific Fundamental Research Collaboration Opportunities." This initiative aims to foster the discovery, development, and integration of novel science and technologies specifically within the Indo-Pacific region, explicitly excluding engagements in the Continental United States. The funding, categorized under Science and Technology and other Research and Development, has an award ceiling of $9.5 million and a floor of $10,000, with an expected 51 awards to be made. Interested applicants can reach out to Mr. Kazuhito Urano or Mr. Joshua B. Grubb for further inquiries, and proposals must be submitted by August 30, 2027, as detailed on the System for Award Management (SAM) website.

Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)

National Institutes of Health

The National Institutes of Health (NIH) is offering a limited competition grant opportunity titled "CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin," aimed at funding fundamental research on skin injuries caused by chemical threats recognized as public health risks. The initiative seeks to enhance understanding of the mechanisms leading to chemical-induced skin injuries and to identify potential therapeutic targets for medical countermeasure development, with a focus on examining two or more Chemicals of Concern, including at least one vesicant. This funding opportunity is crucial for advancing knowledge in the field of chemical threat response and wound healing, with an estimated funding amount of $1.25 million available for fiscal year 2025, allowing for up to five awards capped at $225,000 per year. Applications will open on January 16, 2025, and interested parties can direct inquiries to grantsinfo@nih.gov for further information.

Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

National Institutes of Health

The National Institutes of Health (NIH) is offering a funding opportunity through the Chemical Countermeasures Research Program (CCRP) Initiative, aimed at supporting research on the harmful effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids, such as fentanyl and carfentanil. This initiative seeks to advance understanding of both immediate and delayed health impacts associated with these substances, emphasizing innovative research into toxicity mechanisms and the development of new therapeutic strategies. The program will provide up to four grants, with a maximum award of $300,000 annually over a potential five-year period, totaling an estimated $2 million in funding. Interested applicants, including various educational and nonprofit institutions, must submit their proposals by November 18, 2027, and can direct inquiries to grantsinfo@nih.gov for further information.